Last reviewed · How we verify
vaginal DHEA 6.5 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
vaginal DHEA 6.5 mg (vaginal DHEA 6.5 mg) — Angelica Lindén Hirschberg.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| vaginal DHEA 6.5 mg TARGET | vaginal DHEA 6.5 mg | Angelica Lindén Hirschberg | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- vaginal DHEA 6.5 mg CI watch — RSS
- vaginal DHEA 6.5 mg CI watch — Atom
- vaginal DHEA 6.5 mg CI watch — JSON
- vaginal DHEA 6.5 mg alone — RSS
Cite this brief
Drug Landscape (2026). vaginal DHEA 6.5 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/vaginal-dhea-6-5-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab